Trane Technologies plc · TT · FY2025 Q3 · Calendar Q4 2025
Trane Technologies: Commercial HVAC strength offsets residential weakness
Trane Technologies' Q3 analysis supports a constructive but qualified view: Commercial HVAC, Services, applied-solutions bookings, and data-center demand provide growth support, while lowered organic-growth guidance and weakness in residential and transport refrigeration are important counterweights.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about TT FY2025 Q3
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The growth mix strengthened toward Commercial HVAC, Services, applied solutions, and data centers: applied-solutions bookings more than doubled year over year and chiller capacity had expanded fourfold since 2023. At the same time, FY2025 organic revenue guidance moved to about 6% from about 8% previously, reflecting ongoing residential and transport weakness.
Guidance delta
FY2025 organic revenue growth guidance was about 6%, down from about 8% previously; adjusted EPS guidance was $12.95-$13.05, with 15%-16% growth.
Key takeaways
- Commercial HVAC produced record bookings and a growing backlog, led by applied solutions and data-center demand.
- Applied-solutions bookings more than doubled year over year in Q3, while Services continued low-double-digit growth with higher margins.
- Residential and transport refrigeration remained weak, with inventory normalization expected by year-end.
- Management highlighted continued investment in capacity, connected services, and data-center thermal-management products.
Management priorities
- Expand chiller capacity and other capabilities for data-center projects.
- Reinvest in R&D, including connected services and AI-driven building optimization through BrainBox AI.
- Develop thermal-management products and collaborations, including the NVIDIA reference design.
- Pursue disciplined M&A and continue balanced capital allocation, including share repurchases.
Follow TT with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 4, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Bernstein | Outperform | Outperform | Maintain | Aug 14, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 31, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 31, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 14, 2026 |
| Keybanc | Overweight | Overweight | Maintain | May 1, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 1, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 1, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Jan 30, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 30, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 13, 2026 |
| UBS | Buy | Buy | Maintain | Jan 5, 2026 |
| B of A Securities | Buy | Neutral | Upgrade | Nov 13, 2025 |
| HSBC | Hold | Buy | Downgrade | Jul 31, 2025 |
| Baird | Neutral | Neutral | Maintain | Jul 17, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 8, 2025 |
| Melius Research | Hold | Buy | Downgrade | Jan 28, 2025 |
| Mizuho | Neutral | Neutral | Maintain | Oct 17, 2024 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Aug 5, 2024 |
| TD Cowen | Buy | Buy | Maintain | May 1, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 12, 2023 |
| BMO Capital | Market Perform | Market Perform | Maintain | Feb 12, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 3, 2022 |
| Jefferies | Hold | Hold | Maintain | Jul 15, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Jul 8, 2022 |
| Wolfe Research | Peer Perform | Peer Perform | Maintain | Feb 1, 2022 |
| Vertical Research | Hold | Buy | Downgrade | Jan 3, 2022 |
Named analyst price targets
Upside is calculated against the persisted current price $463.91. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $536 | $438.54 | +15.5% | Sep 24, 2026 |
| Bernstein | Analyst unavailable | $555 | $471.95 | +19.6% | Jul 9, 2026 |
| Bernstein | Analyst unavailable | $550 | $470.76 | +18.6% | Jun 9, 2026 |
| Morgan Stanley | Christopher Snyder | $565 | $484.6 | +21.8% | May 4, 2026 |
| Oppenheimer | Noah Kaye | $530 | $495.64 | +14.2% | May 1, 2026 |
| Mizuho Securities | Brett Linzey | $475 | $495.3 | +2.4% | May 1, 2026 |
| Evercore ISI | Analyst unavailable | $560 | $495.82 | +20.7% | May 1, 2026 |
| KeyBanc | Analyst unavailable | $555 | $492.54 | +19.6% | May 1, 2026 |
| Barclays | Julian Mitchell | $585 | $492.54 | +26.1% | May 1, 2026 |
| KeyBanc | Analyst unavailable | $525 | $477.24 | +13.2% | Apr 21, 2026 |
| BNP Paribas | Andrew Buscaglia | $550 | $472.94 | +18.6% | Apr 14, 2026 |
| Oppenheimer | Noah Kaye | $468 | $426.07 | +0.9% | Jan 30, 2026 |
| Robert W. Baird | Analyst unavailable | $450 | $426.07 | -3.0% | Jan 30, 2026 |
| RBC Capital | Deane Dray | $470 | $426.07 | +1.3% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $507 | $426.07 | +9.3% | Jan 30, 2026 |
| Oppenheimer | Noah Kaye | $460 | $389.53 | -0.8% | Jan 20, 2026 |
| Robert W. Baird | Analyst unavailable | $445 | $381.7 | -4.1% | Jan 12, 2026 |
| Melius Research | Scott Davis | $490 | $381.1 | +5.6% | Jan 7, 2026 |
| Barclays | Julian Mitchell | $505 | $381.1 | +8.9% | Jan 7, 2026 |
| UBS | Analyst unavailable | $520 | $399.28 | +12.1% | Jan 5, 2026 |
| Mizuho Securities | Analyst unavailable | $370 | $398 | -20.2% | Jan 5, 2026 |
| KeyBanc | Analyst unavailable | $500 | $390.84 | +7.8% | Dec 15, 2025 |
| Barclays | Julian Mitchell | $506 | $409.07 | +9.1% | Dec 4, 2025 |
| Robert W. Baird | Analyst unavailable | $500 | $449.42 | +7.8% | Oct 31, 2025 |
| Barclays | Julian Mitchell | $485 | $401.28 | +4.5% | Sep 16, 2025 |
| Stephens | Analyst unavailable | $500 | $433.97 | +7.8% | Aug 4, 2025 |
| HSBC | Wesley Brooks | $460 | $431.44 | -0.8% | Jul 30, 2025 |
| Barclays | Analyst unavailable | $475 | $344.65 | +2.4% | Mar 10, 2025 |
| Wells Fargo | Joseph O'Dea | $380 | $379.96 | -18.1% | Jan 7, 2025 |
| HSBC | Wesley Brooks | $405 | $375.52 | -12.7% | Oct 31, 2024 |
| Stephens | Tommy Moll | $425 | $397.5 | -8.4% | Oct 16, 2024 |
| Robert W. Baird | Timothy Wojs | $408 | $399.86 | -12.1% | Oct 14, 2024 |
| Morgan Stanley | Chris Snyder | $425 | $342.91 | -8.4% | Sep 6, 2024 |
| RBC Capital | Deane Dray | $350 | $334.28 | -24.6% | Aug 1, 2024 |
| Barclays | Julian Mitchell | $380 | $321.5 | -18.1% | Jun 4, 2024 |
| Stephens | Tommy Moll | $320 | $317.34 | -31.0% | May 1, 2024 |
| Mizuho Securities | Brett Linzey | $325 | $312.71 | -29.9% | May 1, 2024 |
| RBC Capital | Deane Dray | $330 | $313.64 | -28.9% | May 1, 2024 |
| Barclays | Julian Mitchell | $354 | $317.34 | -23.7% | May 1, 2024 |
| Goldman Sachs | Analyst unavailable | $203 | $185.73 | -56.2% | Feb 6, 2023 |
| Stephens | Analyst unavailable | $185 | $185.12 | -60.1% | Feb 6, 2023 |
| RBC Capital | Analyst unavailable | $177 | $185.39 | -61.8% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $176 | $185.14 | -62.1% | Feb 3, 2023 |
| Citigroup | Analyst unavailable | $218 | $187.08 | -53.0% | Feb 3, 2023 |
| BMO Capital | John Joyner | $180 | $168.75 | -61.2% | Dec 20, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $155 | $138.44 | -66.6% | Jun 6, 2022 |
| Deutsche Bank | Nicole Deblase | $184 | $167.18 | -60.3% | Feb 1, 2022 |
| Jefferies | Stephen Volkmann | $195 | $175.49 | -58.0% | Jan 24, 2022 |
| Vertical Research | Jeffrey Sprague | $214 | $194.01 | -53.9% | Jan 3, 2022 |
| UBS | Markus Mittermaier | $206 | $198.94 | -55.6% | Dec 14, 2021 |
| Stephens | Tommy Moll | $205 | $179.55 | -55.8% | Nov 4, 2021 |
| BMO Capital | Joel Tiss | $210 | $179.55 | -54.7% | Nov 4, 2021 |
| Robert W. Baird | Timothy Wojs | $200 | $177 | -56.9% | Nov 3, 2021 |
| Cowen & Co. | Gautam Khanna | $200 | $195.81 | -56.9% | Sep 1, 2021 |
| J.P. Morgan | Stephen Tusa | $160 | $191.87 | -65.5% | Aug 9, 2021 |
| Argus Research | John Eade | $220 | $193.39 | -52.6% | Aug 5, 2021 |
| Bank of America Securities | Andrew Obin | $207 | $199.35 | -55.4% | Jul 23, 2021 |
Track every rating change on TT the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationTrane Technologies plc designs, manufactures, sells, and services of solutions for heating, ventilation, air conditioning, and custom and transport refrigeration. It offers air conditioners, exchangers, and handlers; airside and terminal devices; air sourced heat pumps; chillers; coils and condensers; auxiliary power, cold storage, and condensing units; controls contracting and commissioning, decarbonization programs, and gensets; dehumidifiers; energy and water efficiency programs; energy recovery ventilators and power solutions; energy storage; furnaces; home automation; humidifiers; HVAC performance-monitoring products; and indoor air quality assessments and related products for HVAC and transport solutions.…
Historical context
All TT earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the TT recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-04T08:20:49.206538+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-04T08:20:49.204028+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-04. For educational purposes only; not investment advice.